These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 8176477

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies.
    Kobayashi H, Wu C, Yoo TM, Sun BF, Drumm D, Pastan I, Paik CH, Gansow OA, Carrasquillo JA, Brechbiel MW.
    J Nucl Med; 1998 May; 39(5):829-36. PubMed ID: 9591585
    [Abstract] [Full Text] [Related]

  • 3. Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA).
    Camera L, Kinuya S, Garmestani K, Brechbiel MW, Wu C, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH.
    Eur J Nucl Med; 1994 Jul; 21(7):640-6. PubMed ID: 7957350
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H, Wu C, Kim MK, Paik CH, Carrasquillo JA, Brechbiel MW.
    Bioconjug Chem; 1999 Jul; 10(1):103-11. PubMed ID: 9893971
    [Abstract] [Full Text] [Related]

  • 5. 90Yttrium-labeled complementarity-determining-region-grafted monoclonal antibodies for radioimmunotherapy: radiolabeling and animal biodistribution studies.
    Govindan SV, Shih LB, Goldenberg DM, Sharkey RM, Karacay H, Donnelly JE, Losman MJ, Hansen HJ, Griffiths GL.
    Bioconjug Chem; 1998 Jul; 9(6):773-82. PubMed ID: 9815172
    [Abstract] [Full Text] [Related]

  • 6. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 7. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M, Schlom J, Gansow OA, Raubitschek A, Mirzadeh S, Brechbiel MW, Colcher D.
    J Nucl Med; 1989 May; 30(5):672-82. PubMed ID: 2785585
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
    Goodwin DA, Meares CF, Watanabe N, McTigue M, Chaovapong W, Ransone CM, Renn O, Greiner DP, Kukis DL, Kronenberger SI.
    Cancer Res; 1994 Nov 15; 54(22):5937-46. PubMed ID: 7954426
    [Abstract] [Full Text] [Related]

  • 9. In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts.
    Roselli M, Milenic DE, Brechbiel MW, Mirzadeh S, Pippin CG, Gansow OA, Colcher D, Schlom J.
    Cancer Biother Radiopharm; 1999 Jun 15; 14(3):209-20. PubMed ID: 10850305
    [Abstract] [Full Text] [Related]

  • 10. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.
    Kinuya S, Jeong JM, Garmestani K, Saga T, Camera L, Brechbiel MW, Gansow OA, Carrasquillo JA, Neumann RD, Paik CH.
    J Nucl Med; 1994 Nov 15; 35(11):1851-7. PubMed ID: 7965168
    [Abstract] [Full Text] [Related]

  • 11. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.
    Deshpande SV, DeNardo SJ, Kukis DL, Moi MK, McCall MJ, DeNardo GL, Meares CF.
    J Nucl Med; 1990 Apr 15; 31(4):473-9. PubMed ID: 2324823
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a new DTPA-derivative chelator: comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts.
    Camera L, Kinuya S, Garmestani K, Pai LH, Brechbiel MW, Gansow OA, Paik CH, Pastan I, Carrasquillo JA.
    Nucl Med Biol; 1993 Nov 15; 20(8):955-62. PubMed ID: 8298575
    [Abstract] [Full Text] [Related]

  • 13. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.
    Carrasquillo JA, White JD, Paik CH, Raubitschek A, Le N, Rotman M, Brechbiel MW, Gansow OA, Top LE, Perentesis P, Reynolds JC, Nelson DL, Waldmann TA.
    J Nucl Med; 1999 Feb 15; 40(2):268-76. PubMed ID: 10025834
    [Abstract] [Full Text] [Related]

  • 14. Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.
    Lubic SP, Goodwin DA, Meares CF, Song C, Osen M, Hays M.
    J Nucl Med; 2001 Apr 15; 42(4):670-8. PubMed ID: 11337558
    [Abstract] [Full Text] [Related]

  • 15. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
    Goodwin DA, Meares CF, Osen M.
    J Nucl Med; 1998 Oct 15; 39(10):1813-8. PubMed ID: 9776294
    [Abstract] [Full Text] [Related]

  • 16. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 17. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL, Govindan SV, Sharkey RM, Fisher DR, Goldenberg DM.
    J Nucl Med; 2003 Jan 01; 44(1):77-84. PubMed ID: 12515879
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques.
    Lee YC, Washburn LC, Sun TT, Byrd BL, Crook JE, Holloway EC, Steplewski Z.
    Cancer Res; 1990 Aug 01; 50(15):4546-51. PubMed ID: 2164441
    [Abstract] [Full Text] [Related]

  • 19. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.
    McMurry TJ, Pippin CG, Wu C, Deal KA, Brechbiel MW, Mirzadeh S, Gansow OA.
    J Med Chem; 1998 Aug 27; 41(18):3546-9. PubMed ID: 9719608
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA.
    J Nucl Med; 1997 Dec 27; 38(12):1951-9. PubMed ID: 9430476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.